Top Pharmaceuticals, Biotechnology & Life Sciences Companies By Revenue

Revenue
RevenueEfficiencyMarket RiskExp Return
1TAK Takeda Pharmaceutical Co
4.26 T
(0.12)
 0.90 
(0.11)
2RDY Dr Reddys Laboratories
279.16 B
(0.20)
 1.32 
(0.26)
3NVO Novo Nordisk AS
232.26 B
(0.23)
 1.81 
(0.41)
4JNJ Johnson Johnson
85.16 B
(0.11)
 0.79 
(0.09)
5MRK Merck Company
60.12 B
(0.17)
 1.20 
(0.20)
6PFE Pfizer Inc
58.5 B
(0.10)
 1.44 
(0.15)
7ABBV AbbVie Inc
54.32 B
(0.04)
 2.09 
(0.08)
8NVS Novartis AG ADR
46.66 B
(0.22)
 0.99 
(0.22)
9SNY Sanofi ADR
46.03 B
(0.18)
 1.22 
(0.22)
10AZN AstraZeneca PLC ADR
45.81 B
(0.27)
 1.53 
(0.41)
11BMY Bristol Myers Squibb
45.01 B
 0.15 
 2.00 
 0.31 
12TMO Thermo Fisher Scientific
42.86 B
(0.21)
 1.23 
(0.25)
13LLY Eli Lilly and
34.12 B
(0.15)
 1.90 
(0.29)
14GSK GlaxoSmithKline PLC ADR
30.33 B
(0.25)
 1.47 
(0.36)
15AMGN Amgen Inc
28.19 B
(0.15)
 1.69 
(0.25)
16GILD Gilead Sciences
27.12 B
 0.19 
 1.42 
 0.27 
17GMAB Genmab AS
16.47 B
(0.28)
 1.52 
(0.42)
18TEVA Teva Pharma Industries
15.85 B
(0.11)
 1.80 
(0.19)
19VTRS Viatris
15.43 B
 0.07 
 2.29 
 0.17 
20IQV IQVIA Holdings
14.98 B
(0.18)
 1.86 
(0.33)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates. Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.